Strategic Acquisition BioCentric was acquired by Jones Public Affairs, Inc. and fully integrated into JPA Health in 2024, signaling a broader platform for medical communications and healthcare solutions. This creates cross-sell opportunities with JPA Health’s existing client base and expands service depth in clinical and commercial areas.

Integrated Capabilities Post-acquisition, BioCentric’s medical communications and learning solutions are now unified under JPA Health, enabling end-to-end support from science to storytelling. This paves the way for bundled offerings to biopharma clients seeking streamlined, cohesive campaigns.

Growth Indicators Current revenue range is $1M–$10M with a lean team (11–50 employees), suggesting high-margin, targeted engagements. The scale implies potential for upsell into larger programs and expansions as the combined entity targets bigger biopharma accounts.

Tech Enablement Adopted tools include Adobe Creative Suite, AWS, WordPress, HubSpot, and analytics/automation plugins. This tech stack supports scalable creative production, digital marketing, and CRM-driven outreach to accelerate client acquisition and campaign delivery.

Industry Positioning Operating in pharmaceutical manufacturing with a focus on medical communications and learning solutions positions the company to compete with mid-market biology and diagnostics players. Highlighting integration with JPA Health can be leveraged to differentiate through connectivity, end-to-end services, and a unified brand narrative.